JF
LENZ

Jump Financial’s LENZ Therapeutics LENZ Stock Holding History

Jump Financial’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$917K Buy
100,200
+59,349
+145% +$834K 0.01% 966
2025
Q4 		$654K Buy
+40,851
New +$1.19M 0.01% 1171
2024
Q3 		– Sell
-22,611
Closed -$391K – 2196
2024
Q2 		$391K Buy
+22,611
New +$395K 0.01% 1241
2022
Q4 		– Sell
-1,543
Closed -$34K – 2093
2022
Q3 		$34K Sell
1,543
-6,445
-81% -$154K ﹤0.01% 1508
2022
Q2 		$154K Buy
+7,988
New +$178K 0.01% 1362

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Jump Financial's LENZ Position: Q1 2026 in Review

Jump Financial increased its LENZ Therapeutics (LENZ) stake by 145% in Q1 2026, buying an estimated $834K and bringing the position to 100,200 shares worth $917K. The position accounts for 0.01% of the portfolio, ranked #966.

Jump Financial first reported a position in LENZ in Q2 2022 and has held it in 5 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Jump Financial held 100,200 shares of LENZ Therapeutics worth $917K as of Q1 2026.
  • Jump Financial bought 59,349 LENZ Therapeutics shares in Q1 2026, an estimated $834K.
  • LENZ Therapeutics made up 0.01% of Jump Financial's portfolio in Q1 2026, its #966 holding.
  • Jump Financial first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 5 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.